Skip to main content
Clinical Trials/ISRCTN51246892
ISRCTN51246892
Completed
未知

The impact of multiparametric MRI on the staging and management of patients with suspected or confirmed ovarian cancer

Imperial College London (UK)0 sites648 target enrollmentNovember 30, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Imperial College London (UK)
Enrollment
648
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2015
End Date
February 8, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Imperial College London (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Written (signed and dated) informed consent\* prior to mpMRI scan^ and judged capable of co\-operating with study requirements during treatment and follow\-up
  • 2\. Aged 18 years or over
  • 3\. Suspected ovarian, fallopian tube or primary peritoneal cancer. This can be contingent on imaging findings (either on ultrasound or CT) and/or a Risk Malignancy Index Score (RMI) greater than 250
  • 4\. Being considered for up\-front surgery or for interval debulking surgery following neoadjuvant chemotherapy (after 3 to 5 cycles) via the NHS Cancer Pathway”
  • 5\. Considered fit for surgery (by MDT or patient’s surgeon)
  • \*A patient can be enrolled based on verbal consent with written consent to be obtained prior to the mpMRI scan

Exclusion Criteria

  • 1\. Known contraindication to MRI (e.g. claustrophobia, ferrous implants, cardiac pacemaker, inability to lie flat)
  • 2\. Known pregnancy
  • 3\. Medical or psychiatric illness that renders the patient unsuitable or unable to give informed consent
  • 4\. Unable to undergo a CT scan with IV contrast due to allergy, renal failure or any other cause

Outcomes

Primary Outcomes

Not specified

Similar Trials